Urine TMPRSS2:ERG Plus PCA3 for Individualized Prostate Cancer Risk Assessment.

Tomlins SA, Day JR, Lonigro RJ, Hovelson DH, Siddiqui J, Kunju LP, Dunn RL, Meyer S, Hodge P, Groskopf J, Wei JT, Chinnaiyan AM

Open source

DOI
10.1016/j.eururo.2015.04.039
Published
2016 Jul
Container
European urology
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.eururo.2015.04.039,
  title = {Urine TMPRSS2:ERG Plus PCA3 for Individualized Prostate Cancer Risk Assessment.},
  author = {Tomlins SA and Day JR and Lonigro RJ and Hovelson DH and Siddiqui J and Kunju LP and Dunn RL and Meyer S and Hodge P and Groskopf J and Wei JT and Chinnaiyan AM},
  year = {2016},
  journal = {European urology},
  doi = {10.1016/j.eururo.2015.04.039},
  url = {https://doi.org/10.1016/j.eururo.2015.04.039}
}

RIS

TY  - JOUR
TI  - Urine TMPRSS2:ERG Plus PCA3 for Individualized Prostate Cancer Risk Assessment.
AU  - Tomlins SA
AU  - Day JR
AU  - Lonigro RJ
AU  - Hovelson DH
AU  - Siddiqui J
AU  - Kunju LP
AU  - Dunn RL
AU  - Meyer S
AU  - Hodge P
AU  - Groskopf J
AU  - Wei JT
AU  - Chinnaiyan AM
PY  - 2016
JO  - European urology
DO  - 10.1016/j.eururo.2015.04.039
UR  - https://doi.org/10.1016/j.eururo.2015.04.039
ER  - 

APA

SA, T., JR, D., RJ, L., DH, H., J, S., LP, K., RL, D., S, M., P, H., J, G., JT, W., & AM, C. (2016). Urine TMPRSS2:ERG Plus PCA3 for Individualized Prostate Cancer Risk Assessment.. European urology. https://doi.org/10.1016/j.eururo.2015.04.039

Source records